Novocure: A Disruptive Growth Play In Cancer Treatments
November 12, 2020 at 15:01 PM EST
Novocure stock is in a healthy uptrend, prices pulled back substantially in the second half of October, and the stock then found support near the 50-day moving average around $110 on Nov. 3.
